Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers

Distinct ECG phenotypes identified in hypertrophic cardiomyopathy using machine learning associate with arrhythmic risk markers

<p>Aims: Ventricular arrhythmia triggers sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM), yet electrophysiological biomarkers are not used for risk stratification. Our aim was to identify distinct HCM phenotypes based on ECG computational analysis, and characterize differences...

Descripció completa

Dades bibliogràfiques
Autors principals:	Lyon, A, Ariga, R, Minchole, A, Mahmod, M, Ormondroyd, E, Laguna, P, de Freitas, N, Neubauer, S, Watkins, H, Rodriguez, B
Format:	Journal article
Publicat:	Frontiers Media 2018

Ítems similars

Risk stratification in hypertrophic cardiomyopathy based on QRS and T wave morphological biomarkers identifies three phenotypic subgroups
per: Lyon, A, et al.
Publicat: (2016)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
per: Chow, J, et al.
Publicat: (2024)

The arrhythmic substrate of hypertrophic cardiomyopathy using ECG imaging
per: Ji-Jian Chow, et al.
Publicat: (2024-08-01)

Electrocardiogram phenotypes in hypertrophic cardiomyopathy caused by distinct mechanisms: apico-basal repolarization gradients vs. Purkinje-myocardial coupling abnormalities
per: Lyon, A, et al.
Publicat: (2018)

Extraction of morphological QRS-based biomarkers in hypertrophic cardiomyopathy for risk stratification using L1 regularized logistic regression
per: Lyon, A, et al.
Publicat: (2016)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.
per: Passini, E, et al.
Publicat: (2015)

Bridging the Gap Between ECG Indicators of Arrhythmic Risk and the Continuum of Myocardial Disarray and Fibrosis Across Hypertrophic Cardiomyopathy Stages
per: Zakariye Ashkir, MD, et al.
Publicat: (2024-01-01)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
per: Coleman, JA, et al.
Publicat: (2024)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
per: James A. Coleman, et al.
Publicat: (2024-04-01)

ECG-based estimation of dispersion of APD restitution as a tool to stratify sotalol-induced arrhythmic risk.
per: Mincholé, A, et al.
Publicat: (2015)

Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy
per: Coleman, JA
Publicat: (2024)

Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy
per: Masliza Mahmod, et al.
Publicat: (2022-06-01)

Imaging Predictors of Arrhythmic Risk in Genotyped Hypertrophic Cardiomyopathy Patients
per: Safa Daghem, et al.
Publicat: (2024-01-01)

ARRHYTHMIC PHENOTYPE OF NON-COMPACTION CARDIOMYOPATHY
per: S. M. Komissarova, et al.
Publicat: (2021-05-01)

Non-invasive imaging of myocardial disarray associates with ventricular arrhythmia in hypertrophic cardiomyopathy
per: Ariga, R, et al.
Publicat: (2017)

Diffusion tensor magnetic resonance imaging of myocardial disarray in hypertrophic cardiomyopathy
per: Ariga, R, et al.
Publicat: (2018)

Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias
per: Ariga, R, et al.
Publicat: (2019)

Files associated with: "Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy"
per: Coleman, J
Publicat: (2024)

Pseudo-arrhythmic ECG artifact
per: Satyajeet Singh, et al.
Publicat: (2012-01-01)

The Impact of Ischemia Assessed by Magnetic Resonance on Functional, Arrhythmic, and Imaging Features of Hypertrophic Cardiomyopathy
per: Sílvia Aguiar Rosa, et al.
Publicat: (2021-12-01)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry
per: Neubauer, S, et al.
Publicat: (2019)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
per: Blair, E, et al.
Publicat: (2003)

Distinct Phenotypic Groups and Related Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy
per: Soongu Kwak, et al.
Publicat: (2024-10-01)

Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM Registry
per: Neubauer, S, et al.
Publicat: (2019)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
per: Hudsmith, L, et al.
Publicat: (2006)

Pro-arrhythmic Electrophysiological Abnormalities in Subclinical and Overt Hypertrophic Cardiomyopathy; Insights from CMR-ECGI
per: George Joy, MD, et al.
Publicat: (2024-01-01)

Discrepancy between pathological progression and clinical stability in a young patient with hypertrophic cardiomyopathy
per: Raman, B, et al.
Publicat: (2018)

Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications
per: Raman, B, et al.
Publicat: (2018)

Improving the clinical understanding of hypertrophic cardiomyopathy by combining patient data, machine learning and computer simulations: A case study
per: Lyon, A, et al.
Publicat: (2019)

Incremental value of left atrial booster and reservoir strain in predicting atrial fibrillation in patients with hypertrophic cardiomyopathy: a cardiovascular magnetic resonance study
per: Raman, B, et al.
Publicat: (2021)

Computational techniques for ECG analysis and interpretation in light of their contribution to medical advances
per: Lyon, A, et al.
Publicat: (2018)

Restrictive cardiomyopathy and hypertrophic cardiomyopathy overlap: the importance of the phenotype
per: Juan Pablo Kaski, et al.
Publicat: (2012-10-01)

Sudden death in hypertrophic cardiomyopathy.
per: Watkins, H
Publicat: (2000)

Impaired left ventricular energy metabolism in hypertrophic cardiomyopathy is not due to fibrosis.
per: Petersen, SE, et al.
Publicat: (2009)

Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy
per: Doste, R, et al.
Publicat: (2022)

Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy
per: Coleman, J, et al.
Publicat: (2023)

Atypical ECG Presentation of Hypertrophic Cardiomyopathy stimulating Acute Myocardial Infarction
per: Rikesh Tamrakar
Publicat: (2021-04-01)

Adenosine stress T1 mapping: a novel contrast free method to assess myocardial perfusion and ischaemia in hypertrophic cardiomyopathy
per: Raman, B, et al.
Publicat: (2017)

A Genotype-phenotype Taxonomy of Hypertrophic Cardiomyopathy
per: Lara Curran, BSc, et al.
Publicat: (2024-01-01)

Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy.
per: Blair, E, et al.
Publicat: (2001)